This announcement is a separate document:
关于对北京康辰药业股份有限公司2023年度审计报告带强调事项段的无保留意见涉及事项已消除的审核报告
Regarding the unqualified opinion with emphasis on matters related to the audit report of Beijing Konruns Pharmaceutical Co., Ltd. for the year 2023, the relevant issues have been eliminated in the audit report.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated